Lovicu F J, Shin E H, McAvoy J W
Discipline of Anatomy and Histology, Bosch Institute, School of Medical Sciences, University of Sydney, 2006, NSW, Australia; Save Sight Institute, University of Sydney, Sydney 2001, NSW, Australia.
Discipline of Anatomy and Histology, Bosch Institute, School of Medical Sciences, University of Sydney, 2006, NSW, Australia.
Exp Eye Res. 2016 Jan;142:92-101. doi: 10.1016/j.exer.2015.02.004. Epub 2015 May 21.
Cataract is a common age-related condition that is caused by progressive clouding of the normally clear lens. Cataract can be effectively treated by surgery; however, like any surgery, there can be complications and the development of a secondary cataract, known as posterior capsule opacification (PCO), is the most common. PCO is caused by aberrant growth of lens epithelial cells that are left behind in the capsular bag after surgical removal of the fiber mass. An epithelial-to-mesenchymal transition (EMT) is central to fibrotic PCO and forms of fibrotic cataract, including anterior/posterior polar cataracts. Transforming growth factor β (TGFβ) has been shown to induce lens EMT and consequently research has focused on identifying ways of blocking its action. Intriguingly, recent studies in animal models have shown that EMT and cataract developed when a class of negative-feedback regulators, Sprouty (Spry)1 and Spry2, were conditionally deleted from the lens. Members of the Spry family act as general antagonists of the receptor tyrosine kinase (RTK)-mediated MAPK signaling pathway that is involved in many physiological and developmental processes. As the ERK/MAPK signaling pathway is a well established target of Spry proteins, and overexpression of Spry can block aberrant TGFβ-Smad signaling responsible for EMT and anterior subcapsular cataract, this indicates a role for the ERK/MAPK pathway in TGFβ-induced EMT. Given this and other supporting evidence, a case is made for focusing on RTK antagonists, such as Spry, for cataract prevention. In addition, and looking to the future, this review also looks at possibilities for supplanting EMT with normal fiber differentiation and thereby promoting lens regenerative processes after cataract surgery. Whilst it is now known that the epithelial to fiber differentiation process is driven by FGF, little is known about factors that coordinate the precise assembly of fibers into a functional lens. However, recent research provides key insights into an FGF-activated mechanism intrinsic to the lens that involves interactions between the Wnt-Frizzled and Jagged/Notch signaling pathways. This reciprocal epithelial-fiber cell interaction appears to be critical for the assembly and maintenance of the highly ordered three-dimensional architecture that is central to lens function. This information is fundamental to defining the specific conditions and stimuli needed to recapitulate developmental programs and promote regeneration of lens structure and function after cataract surgery.
白内障是一种常见的与年龄相关的病症,由正常透明晶状体的渐进性混浊引起。白内障可通过手术有效治疗;然而,与任何手术一样,可能会出现并发症,继发性白内障的形成,即后囊膜混浊(PCO),是最常见的。PCO是由手术切除纤维团块后留在囊袋中的晶状体上皮细胞异常生长引起的。上皮-间充质转化(EMT)是纤维化PCO和纤维化白内障(包括前/后极性白内障)形成的核心。已表明转化生长因子β(TGFβ)可诱导晶状体EMT,因此研究集中在确定阻断其作用的方法上。有趣的是,最近在动物模型中的研究表明,当一类负反馈调节因子Sprouty(Spry)1和Spry2在晶状体中被条件性缺失时,会发生EMT和白内障。Spry家族成员作为受体酪氨酸激酶(RTK)介导的MAPK信号通路的一般拮抗剂,该信号通路参与许多生理和发育过程。由于ERK/MAPK信号通路是Spry蛋白的一个既定靶点,并且Spry的过表达可以阻断负责EMT和前囊下白内障的异常TGFβ-Smad信号传导,这表明ERK/MAPK通路在TGFβ诱导的EMT中起作用。鉴于此及其他支持证据,有理由关注RTK拮抗剂,如Spry,用于预防白内障。此外,展望未来,本综述还探讨了用正常纤维分化替代EMT从而促进白内障手术后晶状体再生过程的可能性。虽然现在已知上皮到纤维的分化过程由FGF驱动,但对于协调纤维精确组装成功能性晶状体的因素知之甚少。然而,最近的研究为晶状体固有的FGF激活机制提供了关键见解,该机制涉及Wnt-Frizzled和Jagged/Notch信号通路之间的相互作用。这种上皮-纤维细胞的相互作用似乎对于高度有序的三维结构的组装和维持至关重要,而这种结构是晶状体功能的核心。这些信息对于确定重现发育程序以及促进白内障手术后晶状体结构和功能再生所需的特定条件和刺激至关重要。